Publikationen 2010

Stockmann P, Vairaktaris E, Wehrhan F, Seiss M, Schwarz S, Spriewald B, Neukam FW, Nkenke E: (2010) Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up. Support Care Cancer. 2010;18(4): 449-60
Zimmermann R, Witte A, Voll RE, Strobel J, Frieser M: (2010) Coagulation activation and fluid retention associated with the use of black cohosh: a case study. Climacteric. 2010;13(2): 187-91
Guettinger Y, Barbin K, Peipp M, Bruenke J, Dechant M, Horner H, Thierschmidt D, Valerius T, Repp R, Fey GH, Stockmeyer B: (2010) A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alphaRI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cells. J Immunol. 2010;184(3): 1210-7
Ullrich E, Bosch J, Aigner M, Völkl S, Dudziak D, Spriewald B, Schuler G, Andreesen R, Mackensen A: (2010) Advances in cellular therapy: 5th International Symposium on the clinical use of cellular products, 19 and 20 March 2009, Nürnberg, Germany. Cancer Immunol Immunother. 2010;59(11): 1745-56
Weidmann E, Hess G, Chow KU, Krause SW, Subklewe M, Kruse J, Weisel KC, Soekler M, Kim SZ, Napieralski S, Rech J, Dreyling M, Jäger E, Mitrou PS: (2010) A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas. Leuk Lymphoma. 2010;51(3): 447-55
Chankiewitz E, Scholz GA, Spriewald BM, Mackensen A, Bergua A: (2010) [Fundus leucaemicus as first manifestation of chronic myeloid leukemia. Diagnosis and monitoring with OCT under treatment with imatinib and interferon-alpha] Ophthalmologe. 2010;107(4): 359-62
Stein C, Kellner C, Kügler M, Reiff N, Mentz K, Schwenkert M, Stockmeyer B, Mackensen A, Fey GH: (2010) Novel conjugates of single-chain Fv antibody fragments specific for stem cell antigen CD123 mediate potent death of acute myeloid leukaemia cells. Br J Haematol. 2010;148(6): 879-89
Behzad A, Müller A, Rösler W, Amann K, Linke R, Mackensen A: (2010) [Inflammatory myofibroblastic tumor of the lymph node with paraneoplastic thrombosis and eosinophilia] Med Klin (Munich). 2010;105(4): 232-6
Singer H, Kellner C, Lanig H, Aigner M, Stockmeyer B, Oduncu F, Schwemmlein M, Stein C, Mentz K, Mackensen A, Fey GH: (2010) Effective elimination of acute myeloid leukemic cells by recombinant bispecific antibody derivatives directed against CD33 and CD16. J Immunother. 2010;33(6): 599-608
Borkner L, Kaiser A, van de Kasteele W, Andreesen R, Mackensen A, Haanen JB, Schumacher TN, Blank C: (2010) RNA interference targeting programmed death receptor-1 improves immune functions of tumor-specific T cells. Cancer Immunol Immunother. 2010;59(8): 1173-83
Klug M, Heinz S, Gebhard C, Schwarzfischer L, Krause SW, Andreesen R, Rehli M: (2010) Active DNA demethylation in human postmitotic cells correlates with activating histone modifications, but not transcription levels. Genome Biol. 2010;11(6): R63
Winkler J, Rech D, Kallert S, Rech J, Meidenbauer N, Roesler W, Mackensen A: (2010) Sorafenib induces sustained molecular remission in FLT3-ITD positive AML with relapse after second allogeneic stem cell transplantation without exacerbation of acute GVHD: A case report. Leuk Res. 2010;34(10): e270-2
Srivastava MK, Bosch JJ, Wilson AL, Edelman MJ, Ostrand-Rosenberg S: (2010) MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cells. Int J Cancer. 2010;127(11): 2612-21
Kügler M, Stein C, Kellner C, Mentz K, Saul D, Schwenkert M, Schubert I, Singer H, Oduncu F, Stockmeyer B, Mackensen A, Fey GH: (2010) A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting. Br J Haematol. 2010;150(5): 574-86
Schütz C, Oelke M, Schneck JP, Mackensen A, Fleck M: (2010) Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'. Immunotherapy. 2010;2(4): 539-50
Fürnrohr BG, Wach S, Kelly JA, Haslbeck M, Weber CK, Stach CM, Hueber AJ, Graef D, Spriewald BM, Manger K, Herrmann M, Kaufman KM, Frank SG, Goodmon E, James JA, Schett G, Winkler TH, Harley JB, Voll RE: (2010) Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus. Ann Rheum Dis. 2010;69(11): 1983-9
Verheyen J, Schweitzer F, Harrer EG, Knops E, Mueller SM, Daumer M, Eismann K, Bergmann S, Spriewald BM, Kaiser R, Harrer T: (2010) Analysis of immune selection as a potential cause for the presence of cleavage site mutation 431V in treatment-naive HIV type-1 isolates. Antivir Ther. 2010;15(6): 907-12
Dürr C, Pfeifer D, Claus R, Schmitt-Graeff A, Gerlach UV, Graeser R, Krüger S, Gerbitz A, Negrin RS, Finke J, Zeiser R: (2010) CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cells. Cancer Res. 2010;70(24): 10170-81
Singer K, Kastenberger M, Gottfried E, Hammerschmied CG, Buttner M, Aigner M, Seliger B, Walter B, Schlösser H, Hartmann A, Andreesen R, Mackensen A, Kreutz M: (2010) Warburg phenotype in renal cell carcinoma: High expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumor Onkologie. 2010;33 Suppl. (): 128-128
Gündogdu MS, Liu H, Metzdorf D, Hildebrand D, Aigner M, Aktories K, Heeg K, Kubatzky KF: (2010) The haematopoietic GTPase RhoH modulates IL3 signalling through regulation of STAT activity and IL3 receptor expression. Mol Cancer. 2010;9(): 225
Wolff D, Gerbitz A, Ayuk F, Kiani A, Hildebrandt GC, Vogelsang GB, Elad S, Lawitschka A, Socie G, Pavletic SZ, Holler E, Greinix H: (2010) Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. Biol Blood Marrow Transplant. 2010;16(12): 1611-28
Milosevic S, Bachnick B, Karim K, Bornkamm GW, Witter K, Gerbitz A, Mautner J, Behrends U: (2010) Identification of MHC II-restricted minor histocompatibility antigens after HLA-identical stem-cell transplantation. Transplantation. 2010;90(9): 1030-5
Müller-Tidow C, Klein HU, Hascher A, Isken F, Tickenbrock L, Thoennissen N, Agrawal-Singh S, Tschanter P, Disselhoff C, Wang Y, Becker A, Thiede C, Ehninger G, zur Stadt U, Koschmieder S, Seidl M, Müller FU, Schmitz W, Schlenke P, McClelland M, Berdel WE, Dugas M, Serve H, Study Alliance Leukemia , Schulz-Abelius A, Repp R, Klein S, Thiel E, Possinger K, Dörken B, Görner M, Pflüger KH, Mayer J, Hänel M, Pielken HJ, Ehninger G, Aul C, Mackensen A, Dührsen U, Geissler M, Serve H, Kiehl M, Höffkes HG, Schmoll HJ, Schmitz N, Schmidt H, Dürk HA, Ho A, Kaiser U, Pfreundschuh M, Lanska M, Fauser AA, Link H, Bentz M, Wolf M, Dürfeld BM, Löffler LM, Neuhaus T, Fetscher S, Wagner T, Neubauer A, Schleyer E, Griesshammer M, Lutz L, Berdel W, Wandt H, Jakob A, Gaska T, Cetkovsky P, Kozák T, Reichle A, Freund M, Heits F, Geer T, Koch W, Heidemann E, Aulitzky WE, Clemens MR, Frickhofen N, Sandmann M, Einsele H: (2010) Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia. Blood. 2010;116(18): 3564-71

Schriftgröße anpassen

Publikationen 2010

Publikationen 2010

Notfall

Notfallinformationen UKER

Patienten & Besucher

Ärzte & Zuweiser

Forschung

Lehre